Literature DB >> 15644891

Co-induction of methyltransferase Rv0560c by naphthoquinones and fibric acids suggests attenuation of isoprenoid quinone action in Mycobacterium tuberculosis.

Thomas R Garbe1.   

Abstract

The superoxide generator menadione was previously demonstrated as an inducer of growth stage dependent protein patterns in Mycobacterium tuberculosis. The present study refines this observation by characterizing a novel 27-kDa protein that had not been observed in previous studies relying on younger cultures. A very similar response, based on two-dimensional gel electrophoretic analyses, was induced by the closely related naphthoquinone plumbagin. The 27-kDa protein was also induced by the pro-oxidant peroxisome proliferator gemfibrozil and to a lesser extent by the structurally related compounds fenofibrate and clofibrate. N-terminal sequence data of proteolytic fragments from the 27-kDa protein demonstrated its identity with protein Rv0560c, previously demonstrated to be inducible by salicylate, which also possesses peroxisome proliferating properties. Protein Rv0560c bears three conserved motifs characteristic of S-adenosylmethionine-dependent methyltransferases. Further sequence similarities suggest a function in the bio syn thesis of isoprenoid compounds, e.g., tocopherol, ubiquinone, and sterols. Such involvement is supported by the recognized yet unexplained widespread interference of menadione, salicylate, and fibrates with the isoprenoid quinones ubiquinone, menaquinone, and vitamin K. Induction of Rv0560c by fibrates, salicylate, and naphthoquinones is thus suggested to be caused by action on the plasma membrane, reminiscent of cytochrome P450BM-3 induction by fibrates in Bacillus megaterium, which catalyzes the hydroxylation of fatty acids and thus modulates membrane properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15644891     DOI: 10.1139/w04-067

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  6 in total

1.  Mycobacterium tuberculosis Rv0560c is not essential for growth in vitro or in macrophages.

Authors:  Rachel Kokoczka; Dorothée L Schuessler; Julie V Early; Tanya Parish
Journal:  Tuberculosis (Edinb)       Date:  2016-11-05       Impact factor: 3.131

2.  Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria.

Authors:  Céline Rens; Françoise Laval; Mamadou Daffé; Olivier Denis; Rosangela Frita; Alain Baulard; Ruddy Wattiez; Philippe Lefèvre; Véronique Fontaine
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agent.

Authors:  Kathryn Winglee; Shichun Lun; Marco Pieroni; Alan Kozikowski; William Bishai
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

4.  The promoter of Rv0560c is induced by salicylate and structurally-related compounds in Mycobacterium tuberculosis.

Authors:  Dorothée L Schuessler; Tanya Parish
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

5.  Normalization of the levels of inflammatory molecules in Mycobacterium smegmatis-infected U937 cells by fibrate pretreatment.

Authors:  Sung-Jo Kim; Minho Hong; Ki Duk Song; Hak-Kyo Lee; Sungweon Ryoo; Tae-Hwe Heo
Journal:  Biol Res       Date:  2014-09-15       Impact factor: 5.612

6.  AC2P20 selectively kills Mycobacterium tuberculosis at acidic pH by depleting free thiols.

Authors:  Shelby J Dechow; Garry B Coulson; Michael W Wilson; Scott D Larsen; Robert B Abramovitch
Journal:  RSC Adv       Date:  2021-06-04       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.